当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3494040
已选条件
-
T78300Anivovetmab;化合物 AnivovetmabKIND-030;KIND-030
Anivovetmab (KIND-030), an IgG2 type monoclonal antibody targeting the VP2 protein (parvovirus major capsid), offers a potential research avenue for canine parvovirus infection.
价 格:¥电议型 号:T78300产 地:中国大陆
-
T78299Amlitelimab;化合物 AmlitelimabKY1005|||SAR445229;KY1005|||SAR445229
Alvircept sudotox, an anti-OX40 Ligand (OX40L) monoclonal antibody (mAb), disrupts the OX40-OX40L interaction and is used in atopic dermatitis research [1] [2] [3].
价 格:¥电议型 号:T78299产 地:中国大陆
-
T78296IMAB027;化合物 IMAB027ASP1650;ASP1650
IMAB027 (ASP1650) is a specific monoclonal antibody targeting CLDN6 (Claudin 6), a membrane protein of tight junctions aberrantly overexpressed in multiple human cancers, notably in ovarian cancers. This compound exhibits anti-tumor properties and induces apoptosis specifically in CLDN6-positive ovarian and testicular cancer cell lines [1].
价 格:¥电议型 号:T78296产 地:中国大陆
-
T78295Samalizumab;沙马组单抗ALXN 6000;ALXN 6000
Samalizumab (ALXN 6000), a humanized monoclonal antibody, selectively targets and inhibits the interaction between CD200 and its receptor (CD200R). This compound is utilized in the research of multiple myeloma and B-cell chronic lymphocytic leukemia [1].
价 格:¥电议型 号:T78295产 地:中国大陆
-
T78294Tavolixizumab;化合物 TavolixizumabMEDI 0562|||Tavolimab;MEDI 0562|||Tavolimab
Tavolixizumab (also known as MEDI 0562 and Tavolimab) is a human monoclonal antibody targeting TNFRSF4 (TNF receptor superfamily member 4), utilized in cancer immunology studies [1].
价 格:¥电议型 号:T78294产 地:中国大陆
-
T78292Ifinatamab;化合物 IfinatamabAnti-Human B7-H3;Anti-Human B7-H3
Ifinatamab is a monoclonal immunoglobulin G1-kappa antibody that targets the human B7-H3 protein (B7 homolog 3). It functions as a glycoform α immunomodulator [1].
价 格:¥电议型 号:T78292产 地:中国大陆
-
T78291Tregalizumab;化合物 TregalizumabBT-061;BT-061
Tregalizumab, a humanized IgG1-type monoclonal antibody targeting CD4, selectively activates regulatory T cells (Tregs) with suppressive functions in vitro and has potential applications in researching autoimmune diseases (due to inadequate Treg activity) and allergies [1] [2] [3].
价 格:¥电议型 号:T78291产 地:中国大陆
-
T78290Obiltoxaximab;化合物 ObiltoxaximabETI 204;ETI 204
Obiltoxaximab, a powerful monoclonal antibody against protective antigen (PA), is crucial for preventing anthrax toxin assembly and subsequent cell intoxication. Its application extends to dose translation studies from animal models to humans in the context of inhalational anthrax research [1] [2].
价 格:¥电议型 号:T78290产 地:中国大陆
-
T78289Ligelizumab;化合物 LigelizumabQGE 031|||Anti-IGHE Recombinant Antibody;QGE 031|||Anti-IGHE Recombinant
Ligelizumab (QGE 031), a high-affinity humanized monoclonal anti-IgE antibody, is utilized in the research of chronic spontaneous urticaria [1].
价 格:¥电议型 号:T78289产 地:中国大陆
-
T78288Inclacumab;化合物 InclacumabAnti-Human selectin P Recombinant Antibody;Anti-Human selectin P Recombinan
Inclacumab, a humanized monoclonal IgG4 antibody (Anti-Human Selectin P Recombinant Antibody), specifically binds to P-selectin with a dissociation constant (Kd) of 9.9 nM. It effectively prevents the interaction between P-selectin and P-selectin glycoprotein ligand 1 (PSGL-1) mimetic peptide, with a half-maximal inhibitory concentration (IC50) of 1.9 ?g/mL, and robustly impedes cell adhesion [1] [2] [3].
价 格:¥电议型 号:T78288产 地:中国大陆
-
T78287Alsevalimab;化合物 AlsevalimabAlsevalimab
Alsevalimab is a human monoclonal antibody targeting B7-H4 [1].
价 格:¥电议型 号:T78287产 地:中国大陆
-
T78286Rosopatamab;化合物 RosopatamabHJ 591;HJ 591
Rosopatamab (HJ 591) is a humanized monoclonal antibody targeting PSMA, utilized in cancer research with a focus on prostate cancer [1] [2].
价 格:¥电议型 号:T78286产 地:中国大陆
-
T78285Sofituzumab;化合物 SofituzumabMMUC 1206A;MMUC 1206A
Sofituzumab (MMUC 1206A) is a humanized monoclonal antibody targeting the MUC16 antigen, specifically the recombinant V-kappa immunoglobulin variant [1].
价 格:¥电议型 号:T78285产 地:中国大陆
-
T78284Edrecolomab;化合物 EdrecolomabCO17-1A|||Panorex;CO17-1A|||Panorex
Edrecolomab (Panorex), a murine monoclonal antibody targeting the 17-1A cell-surface glycoprotein on epithelial tissues and various carcinomas, exhibits anti-tumor properties and is utilized in colorectal carcinoma research [1] [2].
价 格:¥电议型 号:T78284产 地:中国大陆
-
T78283Caplacizumab;化合物 CaplacizumabALX-0081|||ALX-0681;ALX-0081|||ALX-0681
Caplacizumab (ALX-0681), a humanized anti-von Willebrand factor (vWF) nanobody, serves to impede vWF-mediated platelet adhesion, thereby averting additional microthrombi formation. This compound is utilized in the study of thrombotic thrombocytopenic purpura (TTP) [1].
价 格:¥电议型 号:T78283产 地:中国大陆
-
T78282Tanezumab;化合物 TanezumabRN-624|||PF 4383119;RN-624|||PF 4383119
Tanezumab (RN-624) is a high-affinity, specific humanized anti-NGF monoclonal antibody (mAb) that inhibits nerve growth factor (NGF) from binding to its p75 and TrkA receptors in the peripheral nervous system. It is utilized in research investigating both acute and chronic pain conditions, including osteoarthritis, knee pain, neuralgia, and post-herpetic neuralgia [1] [2].
价 格:¥电议型 号:T78282产 地:中国大陆
-
T78280Fasinumab;化合物 FasinumabFasinumab
Fasinumab (Anti-Human NGF), a human IgG1κ monoclonal antibody targeting nerve growth factor (NGF), has applications in clinical studies for acute sciatica and knee osteoarthritis (OA) [1].
价 格:¥电议型 号:T78280产 地:中国大陆
-
T78279Cixutumumab;化合物 CixutumumabNSC742460|||IMC-A12;NSC742460|||IMC-A12
Cixutumumab (IMC-A12), a humanized monoclonal antibody targeting IGF-1R, exhibits high affinity and inhibits ligand-dependent receptor activation, impeding downstream signaling. Additionally, it facilitates the internalization and degradation of IGF-1R. Demonstrating extensive antitumor efficacy, it is relevant in cancer research, including lung and prostate cancers, malignancies, and leukemia [1].
价 格:¥电议型 号:T78279产 地:中国大陆
-
T78278Blosozumab;化合物 BlosozumabBlosozumab
Blosozumab (LY2541546), an anti-sclerostin (SOST) antibody, promotes bone formation while decreasing bone resorption, with potential applications in osteoporosis research [1] [2].
价 格:¥电议型 号:T78278产 地:中国大陆
-
T78275Ivuxolimab;化合物 IvuxolimabIvuxolimab
Ivuxolimab, an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody, targets a costimulatory receptor found on activated CD4+ and CD8+ T cells. It demonstrates antitumor properties and may exhibit immunostimulatory activity [1].
价 格:¥电议型 号:T78275产 地:中国大陆